Fasudil-lipoic acid dyad and application thereof

A doublet, lipoic acid technology, applied in the field of medicine of the compound

Active Publication Date: 2015-04-29
SUN YAT SEN UNIV
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are no reports in patents and scientific literature that coupling Fasudil and lipoic acid to form

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fasudil-lipoic acid dyad and application thereof
  • Fasudil-lipoic acid dyad and application thereof
  • Fasudil-lipoic acid dyad and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Embodiment 1: the synthesis of fasudil lipoic acid

[0033] (R)-5-(1,2-Dithiolan-3-yl)-1-(4-(isoquinolin-5-ylsulfonyl)-1,4-diazepane-1 -yl)pentan-1-one Add lipoic acid (100mg) and fasudil hydrochloride (158mg) into a dry 25mL round bottom flask, add redistilled dichloromethane solution (5mL), triethylamine (0.18mL) and EDCI (140mg). The reaction solution was stirred overnight at room temperature under the protection of argon, then diluted with ethyl acetate (30 mL), and terminated with saturated aqueous ammonium chloride (3 mL). After separation, the aqueous phase was extracted with ethyl acetate (5 mL×3). The combined organic phases were washed with saturated brine (3 mL×1). in Na 2 SO 4 After drying, the solvent was removed by rotary evaporation, and the residue was purified by silica gel column chromatography (methanol / dichloromethane 1 / 30-1 / 10) to obtain a yellow viscous oil (186mg, 80%). 1HNMR (400MHz, CDCl3) δ9.36(s, 1H), 8.69-8.67(m, 1H), 8.40(d, J=6.1Hz,...

Embodiment 2

[0034] Embodiment 2: computer virtual design

[0035] The X-ray diffraction crystal form of ROCK1 was retrieved from PDB (PDB ID: 2ESM). The binding pocket between them was predicted by MOE (Molecular Operating Environment, Canada) and MOE automatic docking algorithm. Through structure-activity search, 30 preferred binding modes were found. Introduce these combinations to minimize energy and combine calculations, and finally get the best combination. The binding energy and bonding mode were calculated by MOE. From attached figure 1 It can be seen that the isoquinoline ring of Fasudil and L-F 001 can form π-π interaction with the 90 residue of valine, and the homopiperazine ring of Fasudil can interact with the 160 residue of aspartic acid. Two hydrogen bonds are formed, and after LA is inserted, the conformation of the homopiperazine ring changes, and it can no longer form hydrogen bonds with the 160 residue of aspartic acid, and the extra LA part protrudes out of the po...

Embodiment 3

[0036] Example 3: Biological Evaluation

[0037] Inhibitory Effects of Diads on the Activities of Multiple Protein Kinases

[0038] The Z'-LYTE kinase assay kit based on fluorescence resonance energy transfer (Invitrogen, Carlsbad, CA) was used to determine the effect of compounds on ROCK1 (Rho kinase1), ROCK2, PKA (protein kinase A, PKA), PKG (protein kinase G, PKG) kinases IC 50 value. The compound to be tested was configured to 10mM, and then diluted down by 3 times step by step, and a total of 10 concentrations were set. Add 10 μL of reaction solution (containing 2 μM dissolved in 50 mM HEPES, pH7.5, 0.01% Brij-35, 10 mM MgCl 2 , 1 mM EGTA short peptide substrate, and appropriate amount of ROCK1, ROCK2, PKA, PKG) and a series of 3-fold dilutions of the test compound. The final concentration of ATP was 75 μM. After 1 h of incubation, the reaction was terminated, and the fluorescence ratio was calculated according to the instructions. The dose-response curve was fitt...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a synthetic fasudil-lipoic acid dyad. The concrete structural formula of the synthetic fasudil-lipoic acid dyad is shown in the formula (I). The invention further provides a synthesis route of the synthetic fasudil-lipoic acid dyad. The synthetic fasudil-lipoic acid dyad can improve the blood-brain barrier permeability and neuroprotective effect of fasudil to a certain extent and enable fasudil to achieve the effect of multiple-targeted resistance to neurodegenerative diseases.

Description

field of invention [0001] The invention belongs to the medical field of compounds, and relates to a preparation method and application range of a fasudil-lipoic acid doublet, and is mainly applied to neurodegenerative diseases. Background of the invention [0002] Neurodegenerative diseases include Alzheimer's disease, Parkinson's disease, Huntington's disease, etc. The etiology of these diseases has not yet been fully elucidated, but there is solid evidence that oxidative stress, mitochondrial damage, ubiquitin-proteasome dysfunction, excitotoxicity, and inflammatory responses are all involved in the pathogenesis of neurodegenerative diseases. Genomics and proteomics studies have shown that this series of responses interact with each other to jointly promote the occurrence and development of neurodegenerative diseases. With the continuous development of systems biology, it has been found that complex diseases (such as PD, AD, etc.) are not mediated by a single signaling pa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D409/14A61K31/551A61P25/28A61P25/14A61P25/16A61P9/10G01N33/50G01N21/64G01N21/84G01N21/31G01N30/02G01N33/68
CPCC07D409/14G01N33/5014G01N33/542G01N33/94
Inventor 皮荣标陈美惠文石军刘奇周世友刘安民刘培庆
Owner SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products